Leica Biosystems Imaging, Inc.

FDA Regulatory Profile

Leica Biosystems Imaging, Inc. appears in FDA public data with 2 recalls, 3 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-0046-2020, Class II) was initiated on December 10, 2018. Its most recent 510(k) clearance was granted on April 16, 2024.

Summary

Total Recalls
2
510(k) Clearances
3
Inspections
2
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-0046-2020Class IIAperio CS2 CE IVD scanner instrument, scanner part #23CS100CE.December 10, 2018
Z-1152-2014Class IIHER2 Image Analysis Manual Read of HER2 Digital Slides ER/PR Image Analysis IHC PR Breast Tissue February 7, 2014

Recent 510(k) Clearances

K-NumberDeviceDate
K232202Aperio GT 450 DXApril 16, 2024
K190332Aperio AT2 DX SystemMay 20, 2019
K141109APERIO EPATHOLOGY EIHC IVD SYSTEMJuly 29, 2014